Does Methenamine Sodium Phosphate Monobasic Methylene Blue And Hy Interact with Monoamine Oxidase Inhibitors Maois?
Methenamine Sodium Phosphate Monobasic Methylene Blue And Hy and Monoamine Oxidase Inhibitors Maois have a moderate drug interaction according to U.S. FDA drug labeling data. Concurrent use may intensify antimuscarinic side effects. The mechanism involves additive antimuscarinic effects. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.
- Severity
- Moderate
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
How This Interaction Works
The interaction between Methenamine Sodium Phosphate Monobasic Methylene Blue And Hy and Monoamine Oxidase Inhibitors Maois occurs because additive antimuscarinic effects. Clinically, this means concurrent use may intensify antimuscarinic side effects. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.
What To Tell Your Doctor or Pharmacist
If you are taking Methenamine Sodium Phosphate Monobasic Methylene Blue And Hy and your doctor is considering prescribing Monoamine Oxidase Inhibitors Maois (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider